Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET Â | Source: Belite Bio, Inc -Â 500…
OSE Immunotherapeutics met jour linformation sur les procdures en cours
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2,…
DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years
Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently…
ASICS and the Mouratoglou Academy announce global partnership
Over 100 Mouratoglou Academy coaches across France, USA (Zephyrhills, and Atlanta) and…
GENESIS MAGMA RACING TAKES POSITIVES FROM FIRST 24 HOURS OF LE MANS PARTICIPATION
Genesis Magma Racing drivers and team members took valuable lessons from first…
Winner of the Biotherapies and Bioproduction call for projects under the France 2030 plan, EVerZom receives 3 million in government funding to industrialize its exosome bioproduction technology
Winner of the “Biotherapies and Bioproduction” call for projects under the France…
Evosep Joins P4ML to Power Worlds Largest Multi-Omic Human Health Study of Two Million Samples
SAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader…
UN Global Compact CMO Blueprint for Sustainable Growth Takes Centre Stage at Cannes Lions
First-of-Its-Kind Guide Empowering CMOs to Drive Sustainable Business Growth and Impact CANNES,…
AVEROA receives European marketing authorization for XOANACYL, an Oral Therapy for Chronic Kidney Disease (CKD)
XOANACYL is an oral therapy designed to address critical challenges in CKD,…
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
Garching / Munich, Germany, and Grenoble, France, June 16, 2025 – ITM Isotope…